Oceanside, CA, United States of America

Violetta Akopian

USPTO Granted Patents = 19 


 

Average Co-Inventor Count = 11.0

ph-index = 7

Forward Citations = 137(Granted Patents)


Company Filing History:


Years Active: 2014-2021

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Violetta Akopian: Innovator in Therapeutic Agent Delivery

Introduction

Violetta Akopian, a prolific inventor based in Oceanside, CA, is known for her contributions to the field of pharmaceutical formulations. With an impressive portfolio of 19 patents, her work focuses on enhancing the delivery of therapeutic agents, making significant strides in the area of drug delivery systems.

Latest Patents

Two of Violetta's latest patents exemplify her innovative approach to therapeutic delivery. The first patent involves "Lipids for therapeutic agent delivery formulations," which describes ionizable lipids designed to enhance the delivery of therapeutic agents within liposomes. Her second patent, "Cationic lipids for therapeutic agent delivery formulations," details a specific composition that includes a compound with various alkyl and alkenyl groups, providing a versatile framework for improving drug delivery efficacy.

Career Highlights

Violetta Akopian works at Nitto Denko Corporation, where her work on lipid-based formulations stands out. Her extensive experience in pharmaceutical sciences has enabled her to develop technologies that address critical challenges in drug delivery systems. Her contributions are shaping the future of therapeutic agent efficacy.

Collaborations

Throughout her career, Violetta has collaborated with skilled professionals such as Victor Knopov and Richard P. Witte. These collaborations highlight the importance of teamwork in advancing innovative technologies and fostering breakthroughs in therapeutic delivery.

Conclusion

Violetta Akopian exemplifies the spirit of innovation within the pharmaceutical field. Her continued research and development efforts at Nitto Denko Corporation and her patent portfolio signify her dedication to improving therapeutic agent delivery systems. As she advances her work, the implications of her inventions promise to greatly enhance patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…